Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemia

This publication has 18 references indexed in Scilit:

• Acute Lymphoblastic Leukemia
  New England Journal of Medicine, 1998
• RELAPSED LYMPHOBLASTIC LEUKAEMIA IN CHILDREN: A CONTINUING CHALLENGE
  British Journal of Haematology, 1998
• Improved survival with early intensification: combined results from the Medical Research Council childhood ALL randomised trials, UKALL X and UKALL XI
  Leukemia, 1998
• Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology.
  Journal of Clinical Oncology, 1995
• Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia.
  Journal of Clinical Investigation, 1994
• Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01.
  Journal of Clinical Oncology, 1994
• Importance of pharmacodynamics in the in vitro antiproliferative activity of the antifolates methotrexate and 10-ethyl-10-deazaaminopterin against human head and neck squamous cell carcinoma
  Biochemical Pharmacology, 1993
• Basis for natural resistance to methotrexate in human acute non-lymphocytic leukemia
  Leukemia Research, 1991
• Polyglutamation of methotrexate. Is methotrexate a prodrug?
  Journal of Clinical Investigation, 1985
• Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase.
  Journal of Clinical Investigation, 1983